A Study of Continued Treatment With Regorafenib in Participants With Solid Tumors Who Have Participated in Other Bayer Studies
A Study of Continued Treatment With Regorafenib in Participants With Solid Tumors Who Have Participated in Other Bayer Studies
Active, not recruiting · NCT06246643 · Registry updated 2026-09-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Continued Treatment With Regorafenib in Participants With Solid Tumors Who Have Participated in Other Bayer Studies | Solid Malignant Tumors | Active, not recruiting | Phase 2 | 2026-09-23 | NCT06246643 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bayer | 178 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| China Medical University Hospital | Taichung | Taiwan | 24 |
| CHU Lille - Hopital Claude Huriez - Service Gastro-entrologie adulte | Lille | France | 1 |
| Hospital Infantil Universitario Nino Jesus | Oncologia Pediatrica | Madrid | Spain | 1 |
| Hôpital Beaujon - Clichy | Clichy | France | 1 |
| Hôpital Paul Brousse - Villejuif | Villejuif | France | 1 |
| Saitama Cancer Center | Kitaadachi | Japan | 2 |
| Seoul National University Hospital | Oncology | Seoul | South Korea | 1 |